Amer Zeidan, MBBS < Yale School of Medicine

Dr. Amer M. Zeidan

Claim this profile

Yale Cancer Center

Expert in Myelodysplastic Syndrome

Expert in Adult T-Cell Leukemia/Lymphoma

17 reported clinical trials

27 drugs studied

Area of expertise

1Myelodysplastic Syndrome

Global Leader

Amer M. Zeidan has run 12 trials for Myelodysplastic Syndrome. Some of their research focus areas include:

FLT3 positive

TP53 positive

CBF positive

2Adult T-Cell Leukemia/Lymphoma

Global Leader

Amer M. Zeidan has run 11 trials for Adult T-Cell Leukemia/Lymphoma. Some of their research focus areas include:

FLT3 positive

TP53 positive

CBF positive

Affiliated Hospitals

Yale Cancer Center

Yale University

More about Amer M. Zeidan

Clinical Trial Related4 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Amer M. Zeidan has experience with

Azacitidine
Venetoclax
Pembrolizumab
MBG453
Cytarabine
Daunorubicin Hydrochloride

Breakdown of trials Amer M. Zeidan has run

Myelodysplastic Syndrome

Adult T-Cell Leukemia/Lymphoma

Myelodysplastic syndrome

Myeloid Leukemia

Acute Myelogenous Leukemia

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

What does Amer M. Zeidan specialize in?

Amer M. Zeidan focuses on Myelodysplastic Syndrome and Adult T-Cell Leukemia/Lymphoma. In particular, much of their work with Myelodysplastic Syndrome has involved FLT3 positive patients, or patients who are TP53 positive.

Is Amer M. Zeidan currently recruiting for clinical trials?

No, Amer M. Zeidan is not currently recruiting for any clinical trials. This may change in the future, so check back later.

Are there any treatments that Amer M. Zeidan has studied deeply?

Yes, Amer M. Zeidan has studied treatments such as Azacitidine, Venetoclax, Pembrolizumab.

What is the best way to schedule an appointment with Amer M. Zeidan?

Apply for one of the trials that Amer M. Zeidan is conducting.

What is the office address of Amer M. Zeidan?

The office of Amer M. Zeidan is located at: Yale Cancer Center, New Haven, Connecticut 06510 United States. This is the address for their practice at the Yale Cancer Center.

Is there any support for travel costs?

The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

Directories

Locations

Psychology Related

Treatments

Cities

···

Dr. Amer M. Zeidan

Yale Cancer Center

Area of expertise

Affiliated Hospitals

More about Amer M. Zeidan

Other Doctors you might be interested in

Frequently asked questions

Personalize Your Experience

Save Your Preferences

Understand How the Site Is Used